|
Study | Type | Target | Duration of Rx | Dose | Case/control | Outcome |
|
Mader, (1990) [20] | Randomized, placebo-controlled trial | Hyperlipidemic | 12 weeks | 800 mg garlic powder | 130/131 | Dec in T. chol level—12%, TG level—17% |
|
Gadkari and Joshi, (1991) [27] | Randomized control trial | Normal individuals | 2 months | 10 gm of raw garlic | 25/25 | Dec T. chol, increase clotting time, and fibrinolytic activity |
|
Rotzsch et al., (1992) [31] | Randomized, placebo-controlled, double-blind trial | Healthy individuals with low HDL | 6 weeks | 900 mg garlic powder | 12/12 | Dec TG levels and increase HDL levels |
|
Saradeth et al., (1994) [26] | Randomized double-blind study, placebo-controlled trial | Healthy individuals with normal lipid levels | 15 weeks | 600 mg dried garlic powder | 34/34 | T. chol dec from 223 to 214 mg/dL TG dec from 124 to 118 mg/dL |
|
Steiner et al., (1996) [29] | Double-blind crossover trial | Hyperlipidemic | 11 months | 7.2 g aged garlic | 20/21 | Dec T. chol 6.1%, dec LDL 4%, systolic BP 5.5% dec, and modest dec in diastolic Bp noticed |
|
Isaacsohn et al., (1998) [38] | Randomized, double-blind, placebo-control trial | Hyperlipidemic | 12 weeks | 900 mg garlic powder (Kwai) | 28/22 | No change in lipid levels noticed |
|
Berthold et al., (1998) [39] | Double-blind, randomized, placebo-controlled trial | Hyperlipidemic | 12 weeks | 10 mg garlic oil | 12/13 | No change in lipids or lipoproteins levels noticed |
|
Satitvipawee et al., (2003) [37] | Randomized, double-blind, placebo-controlled trial | Hyperlipidemic | 4 weeks/12 weeks | Garlic extract | 70/76 | No dec in T. chol, DL, TG, and HDL levels noticed |
|
Mahmoodi et al., (2006) [30] | Clinical trial | Hyperlipidemic | 42 days | Raw garlic 5 gm twice daily | 30 | Dec T. chol, dec LDL, dec TG, increase HDL level Reversed after stopping of garlic |
|
Sobenin et al., (2008) [28] | Double blinded placebo controlled | Hyperlipidemic | 12 weeks | Allicor (600 mg daily) | 21/21 | T. chol 7.6% dec, LDL 11.8%, and HDL inc 11.5% |
|